302 related articles for article (PubMed ID: 31811020)
21. Targeting Nuclear LSD1 to Reprogram Cancer Cells and Reinvigorate Exhausted T Cells via a Novel LSD1-EOMES Switch.
Tu WJ; McCuaig RD; Tan AHY; Hardy K; Seddiki N; Ali S; Dahlstrom JE; Bean EG; Dunn J; Forwood J; Tsimbalyuk S; Smith K; Yip D; Malik L; Prasanna T; Milburn P; Rao S
Front Immunol; 2020; 11():1228. PubMed ID: 32612611
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic signature of PD-1+ TCF1+ CD8 T cells that act as resource cells during chronic viral infection and respond to PD-1 blockade.
Jadhav RR; Im SJ; Hu B; Hashimoto M; Li P; Lin JX; Leonard WJ; Greenleaf WJ; Ahmed R; Goronzy JJ
Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14113-14118. PubMed ID: 31227606
[TBL] [Abstract][Full Text] [Related]
23. Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8(+) T Cell Exhaustion.
Bengsch B; Johnson AL; Kurachi M; Odorizzi PM; Pauken KE; Attanasio J; Stelekati E; McLane LM; Paley MA; Delgoffe GM; Wherry EJ
Immunity; 2016 Aug; 45(2):358-73. PubMed ID: 27496729
[TBL] [Abstract][Full Text] [Related]
24. Type I interferon signaling attenuates regulatory T cell function in viral infection and in the tumor microenvironment.
Gangaplara A; Martens C; Dahlstrom E; Metidji A; Gokhale AS; Glass DD; Lopez-Ocasio M; Baur R; Kanakabandi K; Porcella SF; Shevach EM
PLoS Pathog; 2018 Apr; 14(4):e1006985. PubMed ID: 29672594
[TBL] [Abstract][Full Text] [Related]
25. Exogenous OX40 stimulation during lymphocytic choriomeningitis virus infection impairs follicular Th cell differentiation and diverts CD4 T cells into the effector lineage by upregulating Blimp-1.
Boettler T; Choi YS; Salek-Ardakani S; Cheng Y; Moeckel F; Croft M; Crotty S; von Herrath M
J Immunol; 2013 Nov; 191(10):5026-35. PubMed ID: 24101548
[TBL] [Abstract][Full Text] [Related]
26. Proliferating Transitory T Cells with an Effector-like Transcriptional Signature Emerge from PD-1
Hudson WH; Gensheimer J; Hashimoto M; Wieland A; Valanparambil RM; Li P; Lin JX; Konieczny BT; Im SJ; Freeman GJ; Leonard WJ; Kissick HT; Ahmed R
Immunity; 2019 Dec; 51(6):1043-1058.e4. PubMed ID: 31810882
[TBL] [Abstract][Full Text] [Related]
27. LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade.
Sheng W; LaFleur MW; Nguyen TH; Chen S; Chakravarthy A; Conway JR; Li Y; Chen H; Yang H; Hsu PH; Van Allen EM; Freeman GJ; De Carvalho DD; He HH; Sharpe AH; Shi Y
Cell; 2018 Jul; 174(3):549-563.e19. PubMed ID: 29937226
[TBL] [Abstract][Full Text] [Related]
28. Correlation of CpG methylation of the Pdcd1 gene with PD-1 expression on CD8
Jiao L; Chen J; Wu X; Cai B; Su Z; Wang L
J Gene Med; 2020 Feb; 22(2):e3148. PubMed ID: 31770816
[TBL] [Abstract][Full Text] [Related]
29. Transcription Factor IRF4 Promotes CD8
Man K; Gabriel SS; Liao Y; Gloury R; Preston S; Henstridge DC; Pellegrini M; Zehn D; Berberich-Siebelt F; Febbraio MA; Shi W; Kallies A
Immunity; 2017 Dec; 47(6):1129-1141.e5. PubMed ID: 29246443
[TBL] [Abstract][Full Text] [Related]
30. Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer.
Kim K; Park S; Park SY; Kim G; Park SM; Cho JW; Kim DH; Park YM; Koh YW; Kim HR; Ha SJ; Lee I
Genome Med; 2020 Feb; 12(1):22. PubMed ID: 32111241
[TBL] [Abstract][Full Text] [Related]
31. Restoring function in exhausted CD8 T cells during chronic viral infection.
Barber DL; Wherry EJ; Masopust D; Zhu B; Allison JP; Sharpe AH; Freeman GJ; Ahmed R
Nature; 2006 Feb; 439(7077):682-7. PubMed ID: 16382236
[TBL] [Abstract][Full Text] [Related]
32. Dissection of antiviral and immune regulatory functions of tumor necrosis factor receptors in a chronic lymphocytic choriomeningitis virus infection.
Suresh M; Gao X; Fischer C; Miller NE; Tewari K
J Virol; 2004 Apr; 78(8):3906-18. PubMed ID: 15047807
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell properties.
Rutishauser RL; Martins GA; Kalachikov S; Chandele A; Parish IA; Meffre E; Jacob J; Calame K; Kaech SM
Immunity; 2009 Aug; 31(2):296-308. PubMed ID: 19664941
[TBL] [Abstract][Full Text] [Related]
34. Effect of chronic viral infection on epitope selection, cytokine production, and surface phenotype of CD8 T cells and the role of IFN-gamma receptor in immune regulation.
Tewari K; Sacha J; Gao X; Suresh M
J Immunol; 2004 Feb; 172(3):1491-500. PubMed ID: 14734726
[TBL] [Abstract][Full Text] [Related]
35. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.
Matloubian M; Concepcion RJ; Ahmed R
J Virol; 1994 Dec; 68(12):8056-63. PubMed ID: 7966595
[TBL] [Abstract][Full Text] [Related]
36. SHP-1 Regulates CD8+ T Cell Effector Function but Plays a Subtle Role with SHP-2 in T Cell Exhaustion Due to a Stage-Specific Nonredundant Functional Relay.
Hou B; Hu Y; Zhu Y; Wang X; Li W; Tang J; Jia X; Wang J; Cong Y; Quan M; Yang H; Zheng H; Bao Y; Chen XL; Wang HR; Xu B; Gascoigne NRJ; Fu G
J Immunol; 2024 Feb; 212(3):397-409. PubMed ID: 38088801
[TBL] [Abstract][Full Text] [Related]
37. Id3 Controls Cell Death of 2B4+ Virus-Specific CD8+ T Cells in Chronic Viral Infection.
Menner AJ; Rauch KS; Aichele P; Pircher H; Schachtrup C; Schachtrup K
J Immunol; 2015 Sep; 195(5):2103-14. PubMed ID: 26232435
[TBL] [Abstract][Full Text] [Related]
38. Blockade of Kv1.3 potassium channel inhibits CD8
Zhao Y; Qiu W; Liu J; Yuan X; Mao W; Yin J; Peng B; Liu W; Han S; He X
FASEB J; 2020 Nov; 34(11):15492-15503. PubMed ID: 32981181
[TBL] [Abstract][Full Text] [Related]
39. TLR4 signaling improves PD-1 blockade therapy during chronic viral infection.
Wang Y; Chung YR; Eitzinger S; Palacio N; Gregory S; Bhattacharyya M; Penaloza-MacMaster P
PLoS Pathog; 2019 Feb; 15(2):e1007583. PubMed ID: 30726291
[TBL] [Abstract][Full Text] [Related]
40. Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8(+) T cells.
Youngblood B; Oestreich KJ; Ha SJ; Duraiswamy J; Akondy RS; West EE; Wei Z; Lu P; Austin JW; Riley JL; Boss JM; Ahmed R
Immunity; 2011 Sep; 35(3):400-12. PubMed ID: 21943489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
